Randomized Controlled Trial
doi: 10.1016/S0140-6736(07)61304-X.
Vascular outcome in type 2 diabetes: an ADVANCE?
Affiliations
- PMID: 17765962
- DOI: 10.1016/S0140-6736(07)61304-X
Item in Clipboard
Randomized Controlled Trial
Vascular outcome in type 2 diabetes: an ADVANCE?
Lancet.
.
No abstract available
Comment in
-
[Commentary to the articles: Kaplan NM. Vascular outcome in type 2 diabetes: an ADVANCE? Lancet 2007; 370:804-5; Patel A; ADVANCE Collaborative Group, MacMahon S, Chalmers J, Neal B i wsp. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet 2007; 370:829-40].Kardiol Pol. 2007 Dec;65(12):1527-9; discussion 1530. Kardiol Pol. 2007. PMID: 18326122 Polish. No abstract available.
Comment on
-
Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial.Lancet. 2007 Sep 8;370(9590):829-40. doi: 10.1016/S0140-6736(07)61303-8. Lancet. 2007. PMID: 17765963 Clinical Trial.
Similar articles
-
[Need of tight blood pressure control in type 2 diabetes. The intervention study ADVANCE gives clear information].Lakartidningen. 2007 Oct 17-23;104(42):3028-9. Lakartidningen. 2007. PMID: 17985709 Swedish. No abstract available.
-
Hypertension arm of ADVANCE defines extent of renal protection using perindopril/indapamide in type 2 diabetics.Cardiovasc J Afr. 2008 Jul-Aug;19(4):226. Cardiovasc J Afr. 2008. PMID: 18776973 No abstract available.
-
The ADVANCE trial.Lancet. 2008 Jan 5;371(9606):25-6; author reply 26. doi: 10.1016/S0140-6736(08)60061-6. Lancet. 2008. PMID: 18177766 No abstract available.
-
Very-low-dose combination of perindopril and indapamide as a novel strategy in first-line management of hypertension.J Hypertens Suppl. 2001 Sep;19(3):S41-5. J Hypertens Suppl. 2001. PMID: 11713850 Review.
-
Efficacy and safety of fixed combination of perindopril and indapamide in type 2 diabetes: results from ADVANCE in context of available evidence.J Hypertens Suppl. 2008 Sep;26(3):S21-7. J Hypertens Suppl. 2008. PMID: 19363849 Review.
Cited by
-
Comparative review of the blood pressure-lowering and cardiovascular benefits of telmisartan and perindopril.Vasc Health Risk Manag. 2014 Apr 5;10:189-200. doi: 10.2147/VHRM.S59429. eCollection 2014. Vasc Health Risk Manag. 2014. PMID: 24741317 Free PMC article. Review.
-
Effectiveness of a group diabetes education programme in under-served communities in South Africa: a pragmatic cluster randomized controlled trial.Diabet Med. 2014 Aug;31(8):987-93. doi: 10.1111/dme.12475. Epub 2014 May 20. Diabet Med. 2014. PMID: 24766179 Free PMC article. Clinical Trial.
-
Control of Hypertension among Diabetic Patients in a Referral Hospital in Tanzania: A Cross-Sectional Study.Ethiop J Health Sci. 2017 Sep;27(5):473-480. doi: 10.4314/ejhs.v27i5.5. Ethiop J Health Sci. 2017. PMID: 29217952 Free PMC article.
-
Hypertension and diabetes: should we treat early surrogates? What are the cons?Diabetes Care. 2009 Nov;32 Suppl 2(Suppl 2):S290-3. doi: 10.2337/dc09-S329. Diabetes Care. 2009. PMID: 19875567 Free PMC article. Review. No abstract available.
-
Managing cardiovascular risk in people with chronic kidney disease: a review of the evidence from randomized controlled trials.Ther Adv Chronic Dis. 2011 Jul;2(4):265-78. doi: 10.1177/2040622311401775. Ther Adv Chronic Dis. 2011. PMID: 23251754 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
